- Conditions: Type 2 Diabetes Mellitus; Atherosclerosis; Dyslipidemia
Intervention: Other: Statin withdrawal
Sponsors: University of Padova; University of Padova
Recruiting - verified May 2012 - Condition: Medication Adherence
Intervention: Other: Increasing Medication Adherence through Physician Incentives and Messaging
Sponsors: National Bureau of Economic Research, Inc.; National Bureau of Economic Research, Inc.; Humana, Inc
Not yet recruiting - verified May 2012 - Condition: HIV Dementia
Interventions: Drug: Lipitor; Drug: placebo
Sponsors: University of Pennsylvania; University of Pennsylvania
Not yet recruiting - verified May 2012 - Conditions: Schizophrenia; Schizoaffective Disorder; Psychosis Not Otherwise Specified; Schizophreniform Disorder
Interventions: Drug: Ondanstron; Drug: Simvastatin; Drug: Placebo
Sponsors: Pakistan Institute of Learning and Living; Pakistan Institute of Learning and Living; Stanley Medical Research Institute; Pakistan Institute of Learning & Living; Dow University of Health Sciences; Karwane Hayat; Abbasi Shaheed Hospital
Recruiting - verified May 2012 - Condition: Hypercholesterolemia
Interventions: Drug: PBO; Drug: 200mg; Drug: 300mg; Drug: PBO; Drug: PF-04950615; Drug: PF-04950615; Drug: PF-04950615
Sponsors: Pfizer; Pfizer
Not yet recruiting - verified May 2012 - Condition: Healthy Volunteers
Interventions: Drug: Digoxin; Drug: Rosuvastatin
Sponsors: Reata Pharmaceuticals, Inc.; Reata Pharmaceuticals, Inc.
Not yet recruiting - verified May 2012 - Condition: Dyslipidemia
Interventions: Drug: Ezetimibe/simvastatin; Drug: Other Statin
Sponsors: Merck; Merck
Not yet recruiting - verified May 2012 - Condition: Atherosclerosis
Interventions: Drug: BMS-962476; Drug: BMS-962476; Drug: BMS-962476; Drug: BMS-962476; Drug: BMS-962476; Drug: BMS-962476; Drug: BMS-962476; Drug: BMS-962476; Drug: Placebo matching with BMS-962476; Drug: Placebo matching with BMS-962476
Sponsors: Bristol-Myers Squibb; Bristol-Myers Squibb
Not yet recruiting - verified April 2012 - Condition: Metabolic Syndrome
Intervention: Drug: Pitavastatin
Sponsors: Kowa Research Europe; Kowa Research Europe
Recruiting - verified May 2012 - Conditions: Diabetic Nephropathy; Persistent Proteinuria With Type II Diabetes
Interventions: Procedure: Percutaneous renal denervation and TMNS; Drug: Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified March 2012 - Condition: Type 1 Diabetes
Interventions: Drug: Statin; Drug: Ace Inhibitor; Drug: Placebo; Drug: Combination therapy
Sponsors: Cambridge University Hospitals NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Juvenile Diabetes Research Foundation; Diabetes UK; British Heart Foundation; Pfizer; The University of Western Australia; The Hospital for Sick Children; University of Oxford; St Thomas' Hospital, London
Recruiting - verified April 2012 - Condition: Angina Pectoris
Interventions: Drug: Rosuvastatin; Drug: Placebo.
Sponsors: Oslo University Hospital; Oslo University Hospital
Not yet recruiting - verified April 2012 - Condition: Mini-Stroke
Intervention: Behavioral: Patient centered structured support program
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany; Technische Universität München; University of Erlangen-Nürnberg Medical School; Praxis für Neurologie und Psychiatrie am Prinzregentenplatz, München; Berlin University of Technology
Recruiting - verified April 2012 - Conditions: Hypertriglyceridaemia; Familial Hypercholesterolaemia
Interventions: Dietary Supplement: Fish oil capsule; Drug: HMG Coenzyme reductase
Sponsors: The University of Western Australia; The University of Western Australia; National Health and Medical Research Council, Australia
Not yet recruiting - verified April 2012 - Condition: Carotid Stenosis
Interventions: Drug: Clopidogrel; Drug: Atorvastatin
Sponsors: Campus Bio-Medico University; Campus Bio-Medico University
Recruiting - verified April 2012 - Conditions: Hyperlipidemia; Hypercholesterolemia; Dyslipidemia
Intervention:
Sponsors: Ohio State University; Ohio State University; National Institute of General Medical Sciences (NIGMS)
Recruiting - verified March 2012 - Conditions: Hyperlipidemia; Hypercholesterolemia; Dyslipidemia
Intervention:
Sponsors: Ohio State University; Ohio State University; National Institute of General Medical Sciences (NIGMS)
Recruiting - verified March 2012 - Condition: Myopathic Symptoms
Interventions: Drug: Ergocalciferol; Drug: Placebo
Sponsors: Cedars-Sinai Medical Center; Cedars-Sinai Medical Center
Recruiting - verified March 2012 - Condition: Coronary Artery Disease
Interventions: Drug: standard of care lipid therapy (Zocor, Lipitor, Crestor); Drug: Aggressive lipid therapy with Crestor 40mg
Sponsors: Mount Sinai School of Medicine; Annapoorna Kini
Recruiting - verified March 2012 - Conditions: Stroke; Transient Ischemic Attack; Hypertension
Intervention: Drug: all approved antihypertensive drugs; all approved statins
Sponsors: Istituto Auxologico Italiano; Istituto Auxologico Italiano; European Society of Hypertension; Chinese Hypertension League
Not yet recruiting - verified March 2012 - Condition: Coronary Artery Disease
Interventions: Drug: Atorvastatin; Drug: Rosuvastatin
Sponsors: University of Roma La Sapienza; University of Roma La Sapienza
Not yet recruiting - verified March 2012 - Condition: Drug-eluting Stent (DES)
Interventions: Drug: Atorvastatin (High dose statin treatment); Drug: Pravastatin (High dose statin treatment)
Sponsors: Yonsei University; Yonsei University
Recruiting - verified March 2012 - Condition: Heart Failure
Interventions: Drug: Withdrawal of statin therapy; Drug: Statin therapy
Sponsors: The Alfred; The Alfred
Recruiting - verified March 2012 - Condition: Prostate Carcinoma
Interventions: Drug: Metformin; Drug: Simvastatin
Sponsors: Baylor College of Medicine; Nicholas Mitsiades
Recruiting - verified March 2012 - Condition: Cardiovascular Disease
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Not yet recruiting - verified March 2012 - Condition: HIV Infection
Intervention: Drug: stop statin and switch to an antiretroviral drug with less impact on lipid metabolism
Sponsors: University Hospital, Geneva; Calmy Alexandra; Janssen-Cilag A.G., Switzerland
Recruiting - verified February 2012 - Conditions: Myocardial Infarction; Peripheral Vascular Disease; Aortic Aneurism
Interventions: Drug: Atorvastatin; Drug: Placebo
Sponsors: Hospital do Coracao; Hospital do Coracao
Not yet recruiting - verified April 2012 - Condition: Lipid Metabolism Disorders
Interventions: Drug: Fluvastatin sodium; Drug: Fluvastatin sodium
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified March 2012 - Condition: Hypercholesterolemia With Concomitant Type 2 Diabetes
Interventions: Drug: Atorvastatin; Drug: Rosuvastatin
Sponsors: Listen Trial Group; Listen Trial Group
Recruiting - verified April 2012 - Condition: Acute Kidney Injury
Interventions: Drug: Atorvastatin(Lipitor); Drug: Placebo
Sponsors: Peking Union Medical College; Peking Union Medical College; Cardiovascular Institute & Fuwai Hospital
Recruiting - verified April 2012 - Conditions: Ventilator-associated Pneumonia; Ischemic Stroke
Interventions: Drug: Atorvastatin; Drug: Placebo
Sponsors: Shanghai Minhang Central Hospital; Shanghai Minhang Central Hospital; Shanghai Jiao Tong University School of Medicine
Recruiting - verified March 2012 - Condition: Atrial Fibrillation
Interventions: Procedure: Cardiac surgery; Procedure: Cardiac surgery
Sponsors: Fundación General Universidad de Valladolid; Fundación General Universidad de Valladolid
Recruiting - verified March 2012 - Condition: Coronary Heart Disease
Intervention:
Sponsors: China National Center for Cardiovascular Diseases; China National Center for Cardiovascular Diseases
Recruiting - verified February 2012 - Condition: Healthy
Intervention: Drug: HCP1007 / omarco and crestor
Sponsors: Hanmi Pharmaceutical Company Limited; Hanmi Pharmaceutical Company Limited
Recruiting - verified March 2012 - Conditions: Atrial Fibrillation; Myocardium; Injury
Interventions: Drug: Rosuvastatin; Drug: Placebo
Sponsors: University of Oxford; University of Oxford; Cardiovascular Institute & Fuwai Hospital; Chinese Academy of Medical Sciences; Peking Union Medical College
Recruiting - verified May 2012 - Conditions: Essential Hypertension; Hyperlipidemia
Interventions: Drug: Atorvastatin; Drug: Losartan; Drug: Placebo; Drug: HL-040XC
Sponsors: HanAll BioPharma Co., Ltd.; HanAll BioPharma Co., Ltd.
Not yet recruiting - verified February 2012 - Condition: Saphenous Vein Graft Disease
Interventions: Drug: Atorvastatin 80 mg daily; Drug: Atorvastatin 10 mg daily
Sponsors: Boca Raton Regional Hospital; Boca Raton Regional Hospital; Pfizer
Recruiting - verified March 2012 - Condition: Nonalcoholic Fatty Liver Disease (NAFLD)
Interventions: Drug: Low dose metformin; Drug: Metformin; Drug: Atorvastatin
Sponsors: University Magna Graecia; Prof Antonino Belfiore
Recruiting - verified February 2012 - Conditions: Acute Myeloid Leukemia/Transient Myeloproliferative Disorder; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Noncutaneous Extranodal Lymphoma; Previously Treated Myelodysplastic Syndromes; Progressive Hairy Cell Leukemia, Initial Treatment; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Lymphoblastic Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; T-cell Large Granular Lymphocyte Leukemia; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia; Untreated Childhood Acute Lymphoblastic Leukemia; Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies; Waldenstrom Macroglobulinemia
Interventions: Drug: atorvastatin calcium; Drug: fludarabine phosphate; Radiation: total-body irradiation; Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation; Drug: cyclosporine; Drug: mycophenolate mofetil; Procedure: peripheral blood stem cell transplantation; Other: laboratory biomarker analysis
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; National Cancer Institute (NCI)
Not yet recruiting - verified February 2012 - Conditions: Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative; Blastic Phase Chronic Myelogenous Leukemia; Burkitt Lymphoma; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Chronic Eosinophilic Leukemia; Chronic Myelomonocytic Leukemia; Chronic Neutrophilic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; de Novo Myelodysplastic Syndromes; Disseminated Neuroblastoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; High Risk Metastatic Gestational Trophoblastic Tumor; Juvenile Myelomonocytic Leukemia; Low Risk Metastatic Gestational Trophoblastic Tumor; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Plasma Cell Neoplasm; Previously Treated Childhood Rhabdomyosarcoma; Previously Treated Myelodysplastic Syndromes; Primary Myelofibrosis; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Rhabdomyosarcoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Gestational Trophoblastic Tumor; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Malignant Testicular Germ Cell Tumor; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Neuroblastoma; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Recurrent Small Lymphocytic Lymphoma; Recurrent Wilms Tumor and Other Childhood Kidney Tumors; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Hairy Cell Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone Lymphoma; Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage II Ovarian Epithelial Cancer; Stage II Ovarian Germ Cell Tumor; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Childhood Hodgkin Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Malignant Testicular Germ Cell Tumor; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Multiple Myeloma; Stage III Ovarian Epithelial Cancer; Stage III Ovarian Germ Cell Tumor; Stage III Small Lymphocytic Lymphoma; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Breast Cancer; Stage IV Childhood Hodgkin Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Ovarian Epithelial Cancer; Stage IV Ovarian Germ Cell Tumor; Stage IV Small Lymphocytic Lymphoma
Interventions: Drug: atorvastatin calcium; Procedure: peripheral blood stem cell transplantation; Procedure: allogeneic hematopoietic stem cell transplantation
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; National Cancer Institute (NCI)
Not yet recruiting - verified February 2012 - Conditions: Recurrent Prostate Cancer; Stage I Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate Cancer
Interventions: Drug: atorvastatin calcium; Drug: placebo
Sponsors: University of Nebraska; University of Nebraska; National Cancer Institute (NCI)
Recruiting - verified March 2012 - Conditions: Hyperlipoproteinemia Type II; Heterozygous Familial Hypercholesterolemia
Interventions: Drug: Anacetrapib; Drug: Placebo for Anacetrapib
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Venous Thromboembolism; Deep Vein Thrombosis; Neoplasms
Interventions: Drug: Rosuvastatin; Drug: Placebo
Sponsors: University of Vermont; University of Vermont
Recruiting - verified March 2012 - Condition: Alopecia Areata
Interventions: Drug: vytorin; Drug: vytorin
Sponsors: University of Miami; University of Miami
Recruiting - verified January 2012 - Conditions: Disorder Related to Renal Transplantation; Hypercholesterolemia
Intervention: Drug: Rosuvastatin
Sponsors: University of Oslo School of Pharmacy; University of Oslo School of Pharmacy; Oslo University Hospital
Recruiting - verified February 2012 - Conditions: Foot Ulcers; Arteriosclerosis Obliterans; Diabetes Mellitus; LDL-apheresis
Intervention: Device: LDL-apheresis
Sponsors: Universita di Verona; Universita di Verona
Recruiting - verified February 2012 - Condition: Schizophrenia
Interventions: Drug: Anti-inflammatory Combination Therapy; Drug: Placebo
Sponsors: University of Maryland; University of Maryland
Not yet recruiting - verified January 2012 - Condition: Psoriasis
Interventions: Drug: Atorvastatin; Drug: Atorvastatin placebo
Sponsors: Rabin Medical Center; shmuel fuchs
Not yet recruiting - verified February 2012 - Condition: Coronary Artery Disease
Interventions: Device: Everolimus Eluting Stent or Zotalolimus Eluting Stent; Drug: ARB, CCB, ACE-inhibitor, statin, Nitrate, Antiplate etc.
Sponsors: Yonsei University; Yonsei University
Recruiting - verified January 2012 - Condition: Vitiligo
Interventions: Drug: Simvastatin; Drug: Placebo
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified April 2012 - Condition: Healthy Subjects
Interventions: Drug: LipoCol Forte capsules; Drug: Lovastatin Tablet
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital; National Science Council, Taiwan
Not yet recruiting - verified February 2012 - Condition: Stroke
Interventions: Procedure: autologous hematopoiesis stem cell transplantation; Drug: Aspirin; Drug: Warfarin; Drug: Atorvastatin; Drug: Edaravone; Drug: Aspirin; Drug: Warfarin; Drug: Atorvastatin; Drug: Edaravone
Sponsors: Zhejiang Hospital; Zhejiang Hospital; Zhejiang University
Recruiting - verified January 2012 - Condition: Hypercholesterolemia
Interventions: Drug: placebo; Drug: SAR236553(REGN727)
Sponsors: Sanofi-Aventis; Sanofi-Aventis; Regeneron Pharmaceuticals
Recruiting - verified May 2012 - Condition: Heart Failure
Interventions: Drug: Atorvastatin; Drug: Placebo
Sponsors: National Taiwan University Hospital; National Taiwan University Hospital
Recruiting - verified November 2011 - Condition: Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension
Interventions: Device: Sirolimus-eluting stent; Device: Biolimus-eluting stents; Drug: pravastatin 20mg/day after DES implantation; Drug: pitavastatin 2mg/day after DES implantation; Drug: Non-ARB /day after DES implantation; Drug: Eposartan 600mg/day after DES implantation
Sponsors: Yonsei University; Yonsei University
Recruiting - verified January 2012 - Condition: Cardiovascular Diseases
Interventions: Drug: AMR101; Drug: Placebo
Sponsors: Amarin Pharma Inc.; Amarin Pharma Inc.
Recruiting - verified March 2012 - Condition: Idiopathic Membranous Nephropathy
Interventions: Drug: symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, Anti-renin, Aldosterone antagonist diuretic, Beta blocker, Calcium inhibitor, statin); Drug: experimental (Non Immunosuppressive Symptomatic Treatment (NIST) and Rituximab)
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified December 2011 - Condition: Coronary Artery Disease
Interventions: Drug: Ezetimibe; Drug: Nutraceuticals
Sponsors: University of Roma La Sapienza; University of Roma La Sapienza
Not yet recruiting - verified December 2011 - Condition: Diabetes Mellitus, Type 2
Interventions: Drug: 1mg Glimepiride/10mg Atorvastatin FDC; Drug: 2mg Glimepiride/10mg Atorvastatin FDC; Drug: 3mg Glimepiride/10mg Atorvastatin FDC; Drug: 4mg Glimepiride/10mg Atorvastatin FDC; Drug: 1mg Glimepiride/20mg Atorvastatin FDC; Drug: 2mg Glimepiride/20mg Atorvastatin FDC; Drug: 3mg Glimepiride/20mg Atorvastatin FDC; Drug: 4mg Glimepiride/20mg Atorvastatin FDC; Drug: 1mg Glimepiride; Drug: 2mg Glimepiride; Drug: 3mg Glimepiride; Drug: 4mg Glimepiride; Drug: 10mg Atorvastatin; Drug: 20mg Atorvastatin
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Recruiting - verified February 2012 - Condition: Hypercholesterolaemia
Intervention:
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified April 2012 - Condition: HMG COA Reductase Inhibitor Adverse Reaction
Interventions: Drug: Vitamin D; Drug: Placebo
Sponsors: Centre hospitalier universitaire de Québec; Centre hospitalier universitaire de Québec; Canadian Institutes of Health Research (CIHR); Laval University
Not yet recruiting - verified December 2011 - Conditions: Hypertension; Cardiovascular Risk Factors
Intervention: Drug: Rosuvastatin
Sponsors: Asan Medical Center; Asan Medical Center; AstraZeneca
Recruiting - verified December 2011 - Conditions: Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndrome
Interventions: Drug: atorvastatin; Drug: Tacrolimus; Drug: methotrexate
Sponsors: Ohio State University Comprehensive Cancer Center; Ohio State University Comprehensive Cancer Center
Recruiting - verified January 2012 - Condition: Healthy
Interventions: Drug: Pravastatin alone; Drug: Pravastatin and Cyclosporine
Sponsors: University of California, San Francisco; University of California, San Francisco; National Institute of General Medical Sciences (NIGMS)
Not yet recruiting - verified December 2011 - Condition: Acute Coronary Syndrome
Interventions: Drug: Pre-procedural High dose atorvastatin loading; Drug: No pre-procedural high-dose atorvastatin loading
Sponsors: The Korean Society of Circulation; The Korean Society of Circulation
Recruiting - verified December 2011 - Conditions: Dyslipidemia; Healthy Volunteers
Intervention: Drug: TAP311
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Cardiovascular Disease; Cerebrovascular Disease; Peripheral Arterial Disease
Intervention: Drug: Cardiovascular Agents
Sponsors: UMC Utrecht; UMC Utrecht
Not yet recruiting - verified January 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin; Drug: Atorvastatin; Other: Placebo to sitagliptin; Other: Placebo to atorvastatin; Drug: Metformin; Drug: Glimepiride; Drug: Placebo to glimepiride
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: HIV-1 Infection
Interventions: Drug: Pravastatin sodium; Drug: Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate; Drug: Pravastatin sodium
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 2012 - Conditions: Cardiovascular Diseases; Coronary Disease; Coronary Artery Disease; Heart Diseases; Myocardial Ischemia
Interventions: Procedure: cardiac catheterization; Procedure: coronary artery bypass graft surgery; Procedure: percutaneous coronary intervention; Behavioral: Lifestyle; Drug: Medication
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI); New York University; Vanderbilt University; Albany Stratton VA Medical Center; East Carolina University; Duke University; Harvard University; University of Missouri, Kansas City; Emory University; Cedars-Sinai Medical Center; Massachusetts General Hospital; University of Calgary; Columbia University; University of British Columbia
Not yet recruiting - verified April 2012 - Conditions: Dyslipidemias; Hypertriglyceridemia; Cardiovascular Diseases
Intervention: Drug: fenofibrate
Sponsors: Abbott; Abbott; RUNDO International Pharmaceuticals Research & Development Co., Ltd
Recruiting - verified April 2012 - Condition: Prostate Cancer
Intervention: Drug: Lovastatin
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Sidney Kimmel Comprehensive Cancer Center
Recruiting - verified April 2012 - Condition: Healthy
Interventions: Drug: Rosuvastatin; Drug: Clopidogrel
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified April 2012 - Condition: Hypercholesterolemia
Intervention: Drug: Rosuvastatin
Sponsors: Seoul National University Hospital; Seoul National University Hospital
Not yet recruiting - verified November 2011 - Condition: Stroke
Interventions: Drug: Anti-platelets and statin; Drug: alteplase; Procedure: intra arterial intervention
Sponsors: Jacobs Neurological Institute; Jacobs Neurological Institute; University at Buffalo Neurosurgery; Genentech
Recruiting - verified March 2012 - Condition: Acute Coronary Syndrome
Interventions: Drug: Atorvastatin; Drug: Placebo
Sponsors: Hospital do Coracao; Hospital do Coracao; Ministry of Health, Brazil
Not yet recruiting - verified February 2012 - Conditions: Renal Failure Chronic Requiring Hemodialysis; Metabolic Syndrome; Diabetes Mellitus Type 2; Hyperlipidemia
Intervention: Drug: Atorvastatin
Sponsors: Poznan University of Medical Sciences; Poznan University of Medical Sciences
Recruiting - verified October 2011 - Condition: Hypercholesterolemia
Intervention: Drug: atrovastatin
Sponsors: Astellas Pharma Inc; Astellas Pharma Inc
Recruiting - verified October 2011 - Condition: Platelet Dysfunction
Interventions: Drug: Atorvastatin; Drug: Rosuvastatin; Drug: Placebo
Sponsors: IRCCS San Raffaele; IRCCS San Raffaele
Recruiting - verified February 2012 - Condition: Cholesterol Embolism Systemic
Interventions: Drug: prednisone; Other: placebo
Sponsors: University Hospital, Toulouse; University Hospital, Toulouse; Ministry of Health, France
Recruiting - verified October 2011 - Condition: Alzheimer's Disease
Intervention: Drug: Simvastatin + L-Arginine + Tetrahydrobiopterin
Sponsors: University of Massachusetts, Worcester; University of Massachusetts, Worcester
Recruiting - verified May 2012 - Condition: Small Cell Lung Carcinoma
Interventions: Drug: IP chemotherapy; Drug: IP chemotherapy with simvastatin
Sponsors: National Cancer Center, Korea; National Cancer Center, Korea
Recruiting - verified November 2011 - Conditions: Immune Reconstitution Inflammatory Syndrome; Immune Reconstitution Syndrome; Tuberculosis; HIV-infection/Aids
Interventions: Drug: Dexamethasone; Drug: Atorvastatin; Drug: Naproxen; Drug: Placebo
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute; Pfizer; Minnesota Medical Foundation
Not yet recruiting - verified April 2012 - Condition: Smith-Lemli-Opitz Syndrome
Interventions: Drug: Simvastatin; Dietary Supplement: Lactose
Sponsors: Oregon Health and Science University; Oregon Health and Science University; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified March 2012 - Condition: Kawasaki Disease
Intervention: Drug: Atorvastatin
Sponsors: University of California, San Diego; University of California, San Diego
Not yet recruiting - verified September 2011 - Condition: Hyperlipidemia
Interventions: Drug: LY3015014 (intravenously); Drug: Placebo (intravenously); Drug: LY3015014 (subcutaneously); Drug: Placebo (subcutaneously)
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified May 2012 - Condition: Coronary Artery Disease
Interventions: Dietary Supplement: Coenzyme Q10; Other: Placebo
Sponsors: Taichung Veterans General Hospital; Taichung Veterans General Hospital
Recruiting - verified August 2011 - Condition: Valvular Cardiac Surgery
Interventions: Drug: Rosuvastatin; Drug: Placebo
Sponsors: McGill University Health Center; McGill University Health Center
Not yet recruiting - verified August 2011 - Conditions: Hypercholesterolemia; Dyslipidemia
Interventions: Drug: Rosuvastatin + Ezetimibe; Drug: Simvastatin + Ezetimibe
Sponsors: Ache Laboratorios Farmaceuticos S.A.; Ache Laboratorios Farmaceuticos S.A.
Not yet recruiting - verified August 2011 - Condition: Advanced Hepatocarcinoma
Intervention: Drug: Pravastatin
Sponsors: Hospital Donostia; Hospital Donostia; INSTITUTO BIODONOSTIA
Recruiting - verified January 2012 - Condition: HMG COA Reductase Inhibitor Adverse Reaction
Interventions: Drug: Vitamin D (Cholecalciferol ); Drug: Placebo
Sponsors: McGill University Health Center; McGill University Health Center
Recruiting - verified July 2011 - Conditions: Hypertension; Dyslipidemia
Intervention: Drug: pitavastatin, valsartan, placebo
Sponsors: JW Pharmaceutical; JW Pharmaceutical
Recruiting - verified July 2011 - Condition: Stable Angina
Interventions: Device: Endothelial cell capture stent with 1 month clopidogrel; Device: Everolimus eluting stent with 12 month clopidogrel; Drug: Atorvastatin 20mg loading; Drug: Atorvastatin 80mg loading
Sponsors: Yonsei University; Yonsei University; OrbusNeich; Yuhan Corporation
Not yet recruiting - verified March 2012 - Condition: ST-Segment Elevation Myocardial Infarction
Interventions: Drug: Ezetimibe; Drug: Placebo
Sponsors: Odense University Hospital; Odense University Hospital
Recruiting - verified June 2011 - Condition: Chronic Hepatitis C
Intervention: Drug: statin
Sponsors: Bader, Ted, M.D.; Bader, Ted, M.D.
Not yet recruiting - verified June 2011 - Condition: ST Elevation (STEMI) Myocardial Infarction
Interventions: Drug: Rosuvastatin 40 mg; Drug: Simvastatin
Sponsors: Helse Stavanger HF; Helse Stavanger HF; Helse Vest; University Hospital of North Norway; St. Olavs Hospital
Not yet recruiting - verified August 2011 - Conditions: Hypertension; Hyperlipidemia
Interventions: Drug: Irbesartan/Atorvastatin A; Drug: Irbesartan; Drug: Atorvastatin A; Drug: Placebo; Drug: Irbesartan/Atorvastatin B; Drug: Atorvastatin B
Sponsors: Hanmi Pharmaceutical Company Limited; Hanmi Pharmaceutical Company Limited
Recruiting - verified September 2011 - Condition: Hyperlipidemia
Interventions: Drug: Pitavastatin; Drug: Atorvastatin
Sponsors: Tai Tien Pharmaceuticals Co., Ltd.; Tai Tien Pharmaceuticals Co., Ltd.
Not yet recruiting - verified June 2011 - Condition: Coronary Artery Disease
Intervention: Drug: Rosuvastatin
Sponsors: University Hospital, Motol; University Hospital, Motol
Recruiting - verified May 2011 - Condition: Healthy
Intervention: Drug: Cilostazol/simvastatin
Sponsors: Samsung Medical Center; Samsung Medical Center; Inje University
Recruiting - verified June 2011 - Conditions: Myocardial Infarction; Unstable Angina
Interventions: Drug: Atorvastatin; Drug: Statin
Sponsors: Xijing Hospital; Xijing Hospital
Recruiting - verified July 2010 - Conditions: Hyperlipidemia; Coronary Artery Disease
Intervention: Drug: Rosuvastatin
Sponsors: Peking University First Hospital; Peking University First Hospital
Recruiting - verified February 2011 - Condition: Pachyonychia Congenita
Intervention: Drug: Simvastatine
Sponsors: Tel-Aviv Sourasky Medical Center; Tel-Aviv Sourasky Medical Center
Not yet recruiting - verified October 2009 - Condition: Stroke
Interventions: Drug: Rosuvastatin; Other: Placebo: Sugar pill
Sponsors: Severance Hospital; Severance Hospital; AstraZeneca
Recruiting - verified February 2010 - Conditions: Pre-diabetes; Pre-hypertension
Interventions: Drug: Metformin+Enalapril+Simvastatin; Drug: Placebo tablet
Sponsors: Ramathibodi Hospital; Ramathibodi Hospital; Ubon Ratchathani Public Health Office, Thailand; National Health Security Office, Thailand; The Government Pharmaceutical Organization
Not yet recruiting - verified May 2011 - Condition: Inflammation
Intervention: Drug: Vytorin
Sponsors: Kaleida Health; Kaleida Health
Recruiting - verified March 2011 - Conditions: Palliative Medicine; Cardiovascular Disease
Intervention: Other: discontinue statins
Sponsors: Palliative Care Research Cooperative Group; Palliative Care Research Cooperative Group; National Institute of Nursing Research (NINR)
Recruiting - verified March 2012 - Conditions: Hepatocellular Carcinoma; CHILD B
Interventions: Drug: sorafenib; Drug: Pravastatin; Drug: Sorafenib + Pravastatin; Other: patients receiving best supportive care
Sponsors: University Hospital, Bordeaux; University Hospital, Bordeaux; Federation Francophone de Cancerologie Digestive; UNICANCER
Not yet recruiting - verified August 2011 - Conditions: Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Recurrent Adult Acute Myeloid Leukemia
Interventions: Drug: cyclosporine; Drug: pravastatin sodium; Drug: mitoxantrone hydrochloride; Drug: etoposide; Procedure: bone marrow aspiration
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Myeloma
Intervention: Drug: Simvastatin,Zoledronic Acid,Bortezomib,Bendamustine,Methylprednisolone.
Sponsors: James Graham Brown Cancer Center; Geoffry Herzig, MD
Recruiting - verified April 2012 - Condition: Cardiovascular Disease
Interventions: Drug: polipillV1; Drug: polipillV2; Drug: usual care
Sponsors: Hospital do Coracao; Hospital do Coracao
Not yet recruiting - verified March 2012 - Conditions: Coronary Artery Disease; Dyslipidemias
Interventions: Drug: Extended release niacin/laropiprant; Drug: placebo
Sponsors: Hospital Italiano de Buenos Aires; Daniel A. Siniawski; Merck
Recruiting - verified October 2011 - Condition: Breast Cancer
Intervention: Drug: rosuvastatin
Sponsors: Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Institute; Massachusetts General Hospital; National Institutes of Health (NIH)
Recruiting - verified February 2012 - Condition: Hyperlipidemias
Interventions: Drug: HMGCoA reductase inhibitor; Drug: HMGCoA reductase inhibitor + probucol; Drug: HMGCA reductase inhibitor + probucol + cilostazol
Sponsors: Seoul National University Hospital; Seoul National University Hospital; Korea Otsuka Pharmaceutical Co.,Ltd.
Recruiting - verified March 2012 - Condition: Fibrosis
Intervention: Drug: Pravastatin
Sponsors: Institut Gustave Roussy; Institut Gustave Roussy; Ministry of Health, France
Recruiting - verified March 2012 - Condition: Statin Myopathy
Intervention: Drug: Individual-specific statin causing myopathy
Sponsors: Lawson Health Research Institute; Lawson Health Research Institute
Recruiting - verified June 2011 - Condition: HIV Dementia
Intervention: Drug: Atorvastatin
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified May 2012 - Conditions: Ischemic Stroke; Transient Ischemic Attack; Atherosclerotic Stenosis
Interventions: Procedure: Target : 100 mg/dL (+/-10 mg/dL); Procedure: 70 mg/dL
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Pfizer; AstraZeneca; Merck
Recruiting - verified December 2009 - Conditions: Cardiotoxicity; Ischemia; Heart Failure
Intervention:
Sponsors: Radboud University; Radboud University
Recruiting - verified October 2010 - Conditions: Diabetes Mellitus, Insulin-Dependent; Hypercholesterolemia
Interventions: Drug: Atorvastatin; Drug: Atorvastatin Placebo
Sponsors: Nemours Children's Clinic; Nemours Children's Clinic; Pfizer; Medtronic; Quest Diagnostics
Recruiting - verified May 2012 - Conditions: Acute Coronary Syndrome; Angioplasty, Transluminal, Percutaneous Coronary; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Blood Platelets
Interventions: Drug: rosuvastatin; Drug: placebo
Sponsors: University of Kentucky; University of Kentucky
Recruiting - verified March 2012 - Condition: HIV-1 Infection
Interventions: Drug: atorvastatin; Drug: atorvastatin
Sponsors: AIDS Clinical Trials Group; AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Pfizer
Recruiting - verified September 2011 - Condition: BRONCHIECTASIS
Intervention: Drug: ATORVASTATIN
Sponsors: University of Edinburgh; University of Edinburgh; NHS Lothian
Recruiting - verified November 2011 - Condition: Bronchiectasis
Intervention: Drug: Atorvastatin
Sponsors: University of Edinburgh; University of Edinburgh; NHS Lothian
Recruiting - verified November 2011 - Condition: Acute Myocardial Infarction
Intervention:
Sponsors: JW Pharmaceutical; JW Pharmaceutical
Recruiting - verified March 2012 - Conditions: Atherosclerosis; Hypercholesterolemia
Interventions: Drug: LDL. Cholesterol (Statin Drugs); Drug: HMG-CoA Reductase Inhibitors
Sponsors: National Institutes of Health Clinical Center (CC); National Institutes of Health Clinical Center (CC)
Recruiting - verified July 2011 - Condition: Migraine
Interventions: Drug: Simvastatin; Dietary Supplement: Vitamin D; Other: Placebo
Sponsors: Beth Israel Deaconess Medical Center; Rami Burstein
Recruiting - verified January 2012 - Conditions: HIV Infections; Heart Disease
Interventions: Drug: Rosuvastatin 10 mg. daily for 96 weeks; Drug: Placebo
Sponsors: University Hospitals of Cleveland; University Hospitals of Cleveland; National Institutes of Health (NIH); AstraZeneca
Recruiting - verified January 2012 - Condition: Myocardial Infarction
Interventions: Drug: Simvastatin 80mg; Drug: Simvastatin 10mg
Sponsors: Brasilia Heart Study Group; Brasilia Heart Study Group
Recruiting - verified October 2010 - Condition: Healthy Volunteers
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Conditions: Dyslipidemias; Hypercholesterolemia; Hypertriglyceridemia; High LDL-C; Low HDL-C
Interventions: Drug: Statin; Drug: Statin
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Bone Metastases of a Malignant Tumor
Interventions: Drug: Aminobiphosphonate; Drug: Simvastatin
Sponsors: VU University Medical Center; VU University Medical Center
Recruiting - verified February 2012 - Conditions: Rheumatic Heart Disease; Congenital Heart Disease; Aneurysm; Heart Valve Disease
Intervention: Drug: Simvastatin
Sponsors: Sun Yat-sen University; Sun Yat-sen University
Recruiting - verified September 2010 - Conditions: Atherosclerosis; Systemic Lupus Erythematosus
Interventions: Drug: Rosuvastatin; Drug: Placebo
Sponsors: Imperial College London; Imperial College London
Recruiting - verified August 2011 - Condition: ST-segment Elevation AMI
Intervention: Drug: Early intensive rosuvastatin therapy (40 mg for 7days, starting in ER prior to primary PCI)
Sponsors: Yonsei University; Yonsei University; CardioVascular Research Foundation, Korea
Recruiting - verified January 2012 - Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Simvastatin; Drug: Lactose tablet
Sponsors: University of Nottingham; University of Nottingham
Recruiting - verified January 2012 - Condition: Non-small Cell Lung Cancer
Interventions: Drug: BIBW 2992; Drug: simvastatin
Sponsors: National Cancer Center, Korea; National Cancer Center, Korea; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified September 2011 - Condition: Hypercholesterolemia
Interventions: Drug: ezetimibe (+) atorvastatin; Drug: Comparator: ezetimibe (+) atorvastatin; Drug: Comparator: atorvastatin, switching to ezetimibe (+) atorvastatin; Drug: Comparator: atorvastatin; Drug: Comparator: rosuvastatin, switching to ezetimibe (+) atorvastatin; Drug: Comparator: rosuvastatin
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Condition: Colorectal Cancer
Intervention: Drug: Simvastatin
Sponsors: Samsung Medical Center; Samsung Medical Center
Recruiting - verified January 2012 - Condition: Statin Myopathy
Interventions: Drug: CoEnzyme Q10; Drug: Placebo
Sponsors: Hartford Hospital; Hartford Hospital
Recruiting - verified January 2012 - Condition: Alzheimer's Disease
Interventions: Drug: Simvastatin; Drug: Placebo
Sponsors: University of Washington; University of Washington; Seattle Institute for Biomedical and Clinical Research; VA Puget Sound Health Care System
Recruiting - verified March 2012 - Condition: Acute Heart Failure
Intervention: Drug: statin
Sponsors: Yonsei University; Yonsei University
Recruiting - verified August 2011 - Condition: Atherosclerosis
Interventions: Device: Enhanced External Counterpulsation (EECP); Drug: statin
Sponsors: Sun Yat-sen University; Sun Yat-sen University
Recruiting - verified May 2010 - Condition: Acute Coronary Syndrome
Intervention: Other: biological parameters dosage
Sponsors: Nantes University Hospital; Nantes University Hospital
Recruiting - verified January 2012 - Condition: Gastric Cancer
Interventions: Drug: Simvastatin; Drug: Placebo
Sponsors: Samsung Medical Center; Samsung Medical Center
Recruiting - verified January 2012 - Condition: Subarachnoid Hemorrhage
Intervention: Drug: Simvastatin
Sponsors: Chinese University of Hong Kong; Chinese University of Hong Kong; Hong Kong Government
Recruiting - verified March 2010 - Conditions: Schizophrenia; Schizoaffective Disorders; Schizophreniform Disorders
Interventions: Drug: Pravastatin; Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Stanley Medical Research Institute; North Suffolk Mental Health Association
Recruiting - verified April 2012 - Condition: Stroke, Acute
Intervention: Drug: Simvastatin
Sponsors: Hospital Universitari Vall d'Hebron Research Institute; Hospital Universitari Vall d'Hebron Research Institute
Recruiting - verified March 2012 - Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: simvastatin; Drug: Placebo
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Condition: Pneumonia
Interventions: Drug: SIMVASTATIN; Drug: PLACEBO
Sponsors: Assistance Publique Hopitaux De Marseille; Assistance Publique Hopitaux De Marseille
Recruiting - verified March 2012 - Condition: Acute Myocardial Infarction
Interventions: Drug: Atorvastatin calcium; Drug: Inactive Placebo
Sponsors: The Western Pennsylvania Hospital; The Western Pennsylvania Hospital; West Penn Allegheny Health System
Recruiting - verified August 2011 - Condition: Myopathy
Intervention:
Sponsors: University of Nottingham; University of Nottingham; The Dunhill Medical Trust
Recruiting - verified October 2011 - Conditions: Cardiovascular Complications; Recurrent Breast Cancer; Stage I Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer
Interventions: Drug: rosuvastatin; Other: placebo; Other: survey administration; Procedure: management of therapy complications
Sponsors: Comprehensive Cancer Center of Wake Forest University; Comprehensive Cancer Center of Wake Forest University; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Condition: Myopathy (Statin Associated)
Intervention:
Sponsors: Rockefeller University; Rockefeller University
Recruiting - verified October 2011 - Condition: Coronary Artery Disease
Intervention: Drug: Pitavastatin 1 mg daily or 4 mg daily
Sponsors: Juntendo University Hospital; Katsumi Miyauchi; Tokyo University; Yamaguchi University Hospital; Tohoku University; Kyoto University; Kumamoto University
Recruiting - verified October 2011 - Condition: Acute Coronary Syndrome
Interventions: Drug: Atorvastatin; Drug: Atorvastatin
Sponsors: Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of Medicine
Recruiting - verified February 2011 - Conditions: Pain; Weakness; Cramps; Myalgia; Side Effects of Statins
Interventions: Dietary Supplement: Coenzyme Q10; Other: Placebo
Sponsors: Beth Israel Deaconess Medical Center; Beth Israel Deaconess Medical Center; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified June 2011 - Conditions: Deep Vein Thrombosis; Venous; Thrombosis; Prevention
Interventions: Drug: Rosuvastatin 20mg/d for 14days; Drug: enoxaparin only
Sponsors: Hallym University Medical Center; Hallym University Medical Center
Recruiting - verified November 2009 - Conditions: Esophageal Cancer; Stomach Cancer
Intervention: Drug: Pravastatin
Sponsors: Hospital Donostia; Hospital Donostia
Recruiting - verified December 2009 - Condition: Dyslipidemia
Interventions: Drug: High-dose rosuvastatin; Drug: Statin plus fenofibrate; Drug: Statin plus niacin ER/laropiprant
Sponsors: University of Ioannina; University of Ioannina
Recruiting - verified November 2009 - Conditions: Colorectal Cancer; Precancerous Condition
Interventions: Drug: rosuvastatin; Other: placebo
Sponsors: National Cancer Institute (NCI); National Surgical Adjuvant Breast and Bowel Project (NSABP); National Cancer Institute (NCI)
Recruiting - verified February 2012 - Condition: Acute Coronary Syndrome
Interventions: Procedure: Percutaneous coronary intervention; Procedure: Intravascular ultrasound with virtual histology; Drug: Atorvastatin; Device: LDL-apheresis
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Conditions: Pain; Soreness; Weakness; Fatigue
Interventions: Dietary Supplement: Co-enzyme Q-10; Dietary Supplement: Placebo
Sponsors: Stony Brook University; Stony Brook University
Recruiting - verified August 2011 - Condition: Hyperglycemia
Interventions: Drug: 5% dextrose; Drug: vitamin C; Drug: Simvastatin; Drug: L-NMMA
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified May 2012 - Conditions: Intestinal Neoplasm; Perioperative Care
Interventions: Drug: Simvastatin; Drug: Placebo
Sponsors: University of Auckland, New Zealand; University of Auckland, New Zealand; Counties Manukau District Health Board; Waitemata District Health Board; Auckland District Health Board
Recruiting - verified November 2011 - Condition: Hepatitis B
Interventions: Drug: Simvastatin; Drug: Tenofovir; Drug: Entecavir
Sponsors: Bader, Ted, M.D.; Bader, Ted, M.D.
Recruiting - verified June 2011 - Conditions: Diabetes Type 2; Hypertension
Interventions: Drug: acetyl-L-carnitine/statin (simvastatin); Drug: placebo
Sponsors: Mario Negri Institute for Pharmacological Research; Mario Negri Institute for Pharmacological Research; Sigma Tau Pharmaceuticals, Inc.
Recruiting - verified June 2011 - Condition: Sepsis Induced ALI
Interventions: Drug: Rosuvastatin; Drug: Placebo
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified May 2012 - Condition: Coronary Artery Disease
Intervention: Drug: Atorvastatin
Sponsors: Indiana University; Indiana University School of Medicine; National Center for Research Resources (NCRR)
Recruiting - verified November 2010 - Conditions: Cardiovascular Disease; HIV; Atherosclerosis; Inflammation; Statins, HMG-CoA; HIV Infections
Interventions: Drug: atorvastatin; Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2012 - Condition: Pancreatic Cancer
Interventions: Drug: Gemcitabine+simvastatin; Drug: Gemcitabine+Placebo
Sponsors: Samsung Medical Center; Samsung Medical Center
Recruiting - verified January 2012 - Conditions: Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Heart Failure
Interventions: Drug: Beta adrenergic blockers; Drug: Platelet inhibitors; Drug: Statins; Drug: ACE inhibitors and/or ARB and/or AA; Procedure: PCI with stenting
Sponsors: Institute of Cardiology, Warsaw, Poland; Institute of Cardiology, Warsaw, Poland
Recruiting - verified January 2012 - Conditions: Type 2 Diabetes; Atherosclerosis
Intervention: Drug: Atorvastatin
Sponsors: Korea University; Korea University
Not yet recruiting - verified July 2009 - Condition: COPD
Interventions: Drug: Rosuvastatin; Drug: Placebo
Sponsors: University Hospital, Akershus; University Hospital, Akershus; AstraZeneca; Haukeland University Hospital, Bergen
Recruiting - verified April 2012 - Condition: Atherosclerosis
Interventions: Drug: Ezetrol (Ezetimibe); Drug: Vytorin (Ezetimibe + Simvastatin)
Sponsors: Korea University; Korea University
Not yet recruiting - verified June 2010 - Conditions: Hypercholesterolemia; HIV Infections
Interventions: Drug: Ezetimibe; Drug: Rosuvastatin (standard care)
Sponsors: University of British Columbia; University of British Columbia; Merck Frosst-Schering Pharma, G.P.
Recruiting - verified November 2011 - Condition: Acute Kidney Dysfunction
Interventions: Drug: Atorvastatin; Drug: Placebo
Sponsors: Austin Health; Austin Health
Recruiting - verified August 2009 - Condition: Healthy
Intervention:
Sponsors: University of Nebraska; University of Nebraska
Recruiting - verified August 2011 - Condition: Atrial Fibrillation
Interventions: Other: Upstream therapy; Other: Conventional rhythm control
Sponsors: University Medical Centre Groningen; University Medical Centre Groningen; Netherlands Heart Foundation; Interuniversity Cardiology Institute Netherlands; Working group Cardiology Netherlands; Trial Coordination Center UMC Groningen; Sanofi-Aventis; Boehringer Ingelheim Pharmaceuticals; Medtronic; Biotronik SE & Co. KG; St. Jude Medical; Boston Scientific Corporation; AstraZeneca
Recruiting - verified April 2009 - Condition: Neurofibromatosis Type 1
Interventions: Drug: Lovastatin ™; Device: placebo
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham; Children's Hospital Boston; Children's Hospital Philadelphia; Children's Research Institute; Children's Hospital Medical Center, Cincinnati; National Cancer Institute (NCI); University of Chicago; University of Utah; Washington University School of Medicine; The Children's Hospital at Westmead
Recruiting - verified July 2011 - Condition: Cardiovascular Disease
Intervention: Drug: Pitavastatin
Sponsors: Juntendo University Hospital; Juntendo University Hospital
Recruiting - verified March 2009 - Conditions: HIV; Hyperlipidemia; HIV Infections
Interventions: Drug: ezetimibe; Drug: fenofibrate; Drug: pravastatin
Sponsors: Ospedale di Circolo - Fondazione Macchi; Ospedale di Circolo - Fondazione Macchi; Merck
Recruiting - verified July 2011 - Condition: Familial Hypercholesterolemia
Intervention: Drug: atorvastatin
Sponsors: Pfizer; Pfizer
Recruiting - verified April 2012 - Condition: Focal Segmental Glomerulosclerosis
Interventions: Drug: Adalimumab; Drug: Lisinopril, losartan, and atorvastatin; Drug: galactose
Sponsors: New York University School of Medicine; New York University School of Medicine; University of Michigan; The Cleveland Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified April 2012 - Conditions: Carotid Artery Stenosis; Atherosclerosis; Stroke
Interventions: Procedure: Carotid Endarterectomy; Drug: atorvastatin, aspirin, losartan, amlodipine
Sponsors: Russian Cardiology Research and Production Center; Russian Cardiology Research and Production Center; Krka, d.d., Novo mesto, Slovenia
Recruiting - verified June 2011 - Conditions: Acute Kidney Injury; Post-Operative Delirium; Icu Delirium; Acute Renal Failure; Delirium
Interventions: Drug: atorvastatin; Drug: placebo
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified July 2011 - Condition: HDL Cholesterol
Interventions: Drug: Simvastatin; Drug: Atorvastatin 80 mg
Sponsors: Oregon Health and Science University; Oregon Health and Science University; Merck; Oregon State University; Indiana University
Recruiting - verified August 2008 - Condition: Subarachnoid Haemorrhage
Interventions: Drug: placebo; Drug: simvastatin
Sponsors: Cambridge University Hospitals NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; British Heart Foundation
Recruiting - verified June 2011 - Condition: Statin Induced Myalgia
Interventions: Drug: Coenzyme Q 10; Drug: Placebo control
Sponsors: Hadassah Medical Organization; Hadassah Medical Organization
Recruiting - verified September 2010 - Conditions: Dyslipidemia; Atherosclerosis
Interventions: Drug: simvastatin; Drug: Nicotinic Acid
Sponsors: Medical University of Vienna; Medical University of Vienna
Recruiting - verified July 2011 - Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Lovastatin; Drug: Placebo
Sponsors: National Jewish Health; National Jewish Health; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2011 - Condition: Severe Persistent Asthma
Interventions: Drug: Lovastatin; Drug: Placebo
Sponsors: University of Chicago; University of Chicago
Not yet recruiting - verified August 2011 - Conditions: HIV Infections; Hyperlipidemia
Intervention: Drug: Atorvastatin
Sponsors: International Maternal Pediatric Adolescent AIDS Clinical Trials Group; International Maternal Pediatric Adolescent AIDS Clinical Trials Group; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified May 2012 - Conditions: Cancer; Prostate
Interventions: Drug: Simvastatin; Other: Placebo
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs; Oregon Health and Science University
Recruiting - verified May 2012 - Condition: Prostate Cancer
Intervention: Drug: lovastatin
Sponsors: Virginia Commonwealth University; Virginia Commonwealth University; Hunter Holmes Mcguire Veteran Affairs Medical Center
Recruiting - verified April 2012 - Condition: Coronary Heart Disease
Interventions: Behavioral: smoking cessation; Drug: betablocker, diuretics, ACEI, ARB,; Drug: statins (simvastatin, atorvastatin), ezetimib; Behavioral: training; Biological: influenza vaccine; Drug: metformin, glimepiride, insulin; Behavioral: weight reduction
Sponsors: Sorlandet Hospital HF; Sorlandet Hospital HF; Ullevaal University Hospital
Recruiting - verified December 2011 - Condition: Lung Cancer
Interventions: Drug: carboplatin; Drug: cisplatin; Drug: etoposide phosphate; Drug: pravastatin sodium
Sponsors: University College, London; University College, London
Recruiting - verified December 2011 - Condition: Atrial Fibrillation
Interventions: Drug: Simvastatin; Drug: Placebo
Sponsors: University of Calgary; University of Calgary; Merck; Canadian Institutes of Health Research (CIHR)
Recruiting - verified December 2011 - Condition: Rheumatoid Arthritis
Interventions: Drug: Lovastatin; Device: Lovastatin placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institute of Allergy and Infectious Diseases (NIAID); Autoimmunity Centers of Excellence
Recruiting - verified September 2011 - Conditions: Diabetes Mellitus; Glucose Intolerance
Interventions: Other: life-style intervention; Drug: Life style intervventions plus concomitant use of pitavastatin.
Sponsors: Tokyo University; Tokyo University
Recruiting - verified April 2012 - Condition: Sarcoidosis, Pulmonary
Intervention: Drug: Atorvastatin
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified August 2011 - Conditions: Schizophrenia; Schizoaffective Disorder; Major Depression; Bipolar Disorder; Coronary Artery Disease
Interventions: Drug: Eicosapentaenoic acid (omega-3 fatty acid); Drug: Placebo
Sponsors: University of Pittsburgh; University of Pittsburgh; American Heart Association; VA Pittsburgh Healthcare System
Recruiting - verified October 2011 - Conditions: Leukemia; Lymphoma, Non-Hodgkin
Interventions: Drug: Atorvastatin; Procedure: CT scan of chest/abdomen/pelvis
Sponsors: Stanford University; Stanford University; The Leukemia and Lymphoma Society; Damon Runyon Cancer Research Foundation; Burroughs Wellcome
Recruiting - verified November 2011
 |
Statins - Drugs by Classification - Medications / Interventions - Join Paid Clinical Trials |
